Your browser doesn't support javascript.
loading
Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma.
Zhang, Xiaoling; Zhou, Yuxin; Hu, Jiahe; Yu, Xuefeng; Xu, Haitao; Ba, Zhichang; Zhang, Haoxin; Sun, Yanan; Wang, Rongfang; Du, Xinlian; Mou, Ruishu; Li, Xuedong; Zhu, Jiuxin; Xie, Rui.
Affiliation
  • Zhang X; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Zhou Y; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Hu J; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Yu X; Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Xu H; Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Ba Z; Medical Imaging Center, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Zhang H; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Sun Y; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Wang R; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Du X; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Mou R; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Li X; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China.
  • Zhu J; Department of Pharmacology (National Key Laboratory of Frigid Zone Cardiovascular Diseases, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, 15008
  • Xie R; Department of Digestive Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, 150081, China. rxie@hrbmu.edu.cn.
BMC Cancer ; 23(1): 560, 2023 Jun 17.
Article in En | MEDLINE | ID: mdl-37330494

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication: